Paper
0
Utility of bioselection with neoadjuvant chemotherapy for organ preservation in patients with T4 laryngeal cancer
Authors
Journal
Published
Sep 1, 2024
Show more
Save
Tip0
TipSave
Abstract
Neoadjuvant chemotherapy for induction selection of definitive treatment (IS) protocols have shown excellent outcomes for organ preservation and survival in patients with T3 laryngeal squamous cell carcinoma (LSCC). We seek to evaluate survival and organ preservation outcomes in T4 LSCC patients treated with IS protocols.
Paper PDF
This paper's license is marked as closed access or non-commercial and cannot be viewed on ResearchHub. Visit the paper's external site.